Transplant Diagnostics Market to Reflect Impressive Growth Rate by Method Type – Pre-Transplant Screening and Post-Transplant Screening during 2018 – 2023

Transplant Diagnostics Market
Transplant Diagnostics Market report gives expected growth of Top players at CAGR 7.2% during the forecast period of 2018–2023. Global Transplant Diagnostics Market is segmented on the basis of products into instrument, reagent, software and services.

Transplant diagnostic is the method used to diagnose the compatibility of the replaced organ. Organ transplantation is a medical procedure in which an organ is removed from the one boy and placed in other body to swap the damaged or missing organ. Kidney is the most widely transplanted organ across the world. 

Global Transplant Diagnostics Market is driven by increasing number of transplantation procedures across the globe. Increasing prevalence of chronic diseases, advanced in the diagnostic methods and increasing healthcare expenditure has also contributed in the growth of the market. On other hand, limited number of donor and high cost of diagnostic method has hamper the growth of the market. Global transplant diagnostics market is expected to grow at a CAGR of 7.2% during forecasted period.

Antibody-mediated refusal of organ allografts is difficult to treat as barriers following allotransplantation. Enhanced diagnostics has permitted better detection and specificity-determination of antibodies precise for a donor Human Leukocyte Antigens (HLA). Nevertheless, antibodies which are also against non-HLA antigens are of importance for graft function. We have established a novel crossmatch test that simplifies detection of donor-specific non-HLA particular antibodies prior to transplantation. Doctors and expert physicians are presently refining this test which allows detection of complement-fixing non-HLA antibodies. Additionally, studies are going on to assess the occurrence of non-HLA specific antibodies in kidney graft inheritors post-transplant as well as at the time of rejection.

A substantial problem in clinical transplantation is the lack of donor tissue/organs for transplantation. One of the possible solutions to this problem is the use of tissues/organs/ cells from animals for transplantation to man, which is also known as xenotransplantation. Because xenografts are dynamically rejected, studies on the reasons for this rejection are essential. In particular specialists are interested in evaluating co-stimulation blockade as a means of undertaking long-term pancreatic islet xenograft survival.

Global Transplant Diagnostics Market – Competitive Analysis

Thermo Fisher Scientific Acquires Linkage Bio: on July 2017 Thermo Fisher Scientific confirmed the company’s acquisition of Linkage Biosciences for an undisclosed amount, as a result of this acquisition Linkage Biosciences is now a part of Thermo Fisher’s transplant diagnostics business. The company based in South San Francisco, California. Benefits involved from the acquisition include a broader and deeper range of products, a continued commitment to innovation, and expanded support globally.

The business is extremely complementary to the company’s One Lambda tests, which regulate the compatibility of donors and recipients pre- and post-transplant. This acquisition further expands Thermo Fisher’s commitment of improving transplant patients’ quality of life over innovative high-quality products for the clinical and research segments of the transplant community.

Get Sample Report @ .

Global Transplant Diagnostics Market – Key Players

Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Becton Dickinson and Company (US), Abbott Laboratories Inc (US), CareDx (US), QIAGEN N.V. (Netherlands), Immucor, Inc. (US), GenDx (Netherlands), Omixon Ltd. (UK), bioMérieux S.A. (France), Illumina, Inc. (US), Immucor Transplant Diagnostics, Inc (US), Affymetrix, Inc (US), Linkage Biosciences (US) 

Global Transplant Diagnostics Market – Segmentation

Global transplant diagnostics market is segmented on the basis of products into instrument, reagent, software and services. On the basis of technology the market is segmented into non-molecular assay and molecular assay. Non-molecular is further segmented into serological assay and mixed lymphocyte culture. Molecular assay is further segmented into sequenced base and PCR based. On the basis of application the market is segmented into heart, lungs, liver, kidney and other. On the basis of method type the market is segmented into pre-transplant screening and post-transplant screening and on the basis of end user the market is segmented as hospitals, transplants centers, research laboratories and other.

Thermo Fisher Scientific, Inc is American multinational company headquartered in US. Thermo Fisher Scientific, Inc. holds the first position in the global transplant diagnostics market. Company has introduces different antibody, HLA Transplant Diagnostics Products, transplant-related biomarker and many more. Electro-Fast and OWL Centipede systems and DNA Isolation Kit are the products of the company. SeCore one of the product for high-resolution HLA typing products. Company has introduced PlexMark which is a highly specific assay with extremely low cross-reactivity perform during renal transplants.
Bio-Rad Laboratories, Inc. is the US headquartered company which develops, manufacture and market the wide range of products for clinical diagnostics and research. In Feb 2016, company has got approval for the QX200, Droplet Digital PCR System which are the first digital PCR system with the CE IVD mark for use as an in vitro diagnostic equipment. 

Global Transplant Diagnostics Market – Regional Analysis

Geographically, America dominated the global transplant diagnostics market. Increasing demand for the advanced techniques and diagnostic tools and higher healthcare expenditure are the major factor for the growth of the America market. Europe is the second largest transplant diagnostics market which is followed by Asia Pacific. Asia pacific is the fastest growing region for this market. Large population pole suffering from chronic diseases is the major driving factor for the Asia Pacific market. 

Major Table of Content

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics


To Know More Enquire @  

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312


Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India